Oral tablet for moderate to severe plaque psoriasis
Treatments studied
Part of Skin clinical trials.
This trial tests an oral tablet (CMS-D001) for adults with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing psoriasis severity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had plaque psoriasis for at least 6 months.
- Your psoriasis covers at least 10% of your body (like 10 palms of your hand) and it is moderate to severe.
- Your doctor says you could try light therapy or systemic medications (pills or injections).
- You do not have active serious infections, tuberculosis, hepatitis B or C, HIV, or certain other health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called HS-20137 for people with moderate to severe plaque psoriasis. It might help reduce skin symptoms like redness, scaling, and itching.
This study tests a new injectable medicine for people with moderate-to-severe plaque psoriasis. It aims to see if it is safe and effective at reducing symptoms like redness and scaling.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This trial tests an experimental drug called ICP-488 for people with moderate to severe plaque psoriasis. It aims to see if the drug can improve symptoms and is safe, and may be an option if you need stronger treatment than creams or light therapy.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This study tests a new oral pill (HSK47388) for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing the severity and area of psoriasis over 12 weeks.
Hear when a new Moderate to Severe Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.